Catalyst Wire Dossier Catalyst Wire Dossier

Renin-Angiotensin System blockade

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Renin-Angiotensin System blockade, covering 2009-06-03 to 2009-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria [Phase 4]

See pricing